[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature-Reference-Cited by-同舟云学术

[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature

Published:2022-06 Issue:3 Volume:5 Page:273-282
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Evangelista Laura,Maurer Tobias,van der Poel Henk,Alongi Filippo,Kunikowska Jolanta,Laudicella Riccardo,Fanti Stefano,Hofman Michael S.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference36 articles.

1. Prostate-specific membrane antigen ligands for imaging and therapy;Eiber;J Nucl Med,2017

2. Prostate-specific membrane antigen PET: Clinical utility in prostate cancer, normal patterns, pearls, and pitfalls;Hofman;Radiographics,2018

3. Comparing the staging/restaging performance of 68Ga-labeled prostate-specific membrane antigen and 18F-choline PET/CT in prostate cancer: a systematic review and meta-analysis;Lin;Clin Nucl Med,2019

4. PSMA-targeted radiopharmaceuticals for imaging and therapy;Wester;Semin Nucl Med,2019

5. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study;Gafita;Lancet Oncol,2021

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics;Radiotherapy and Oncology;2024-10

2. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [¹⁸F]PSMA-1007 PET/CT;Journal of Nuclear Medicine;2024-09-05

3. PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration;Clinical and Translational Imaging;2024-09-03

4. Evaluating the added value of concurrent contrast-enhanced diagnostic CT for PSMA-PET/CT Interpretation;Academic Radiology;2024-08

5. Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?;Bioengineering;2024-07-14